Showing results (181-190 of 583) with videos related to
Sort By:
Pageof 59
British Journal of Pharmacology|November 1, 1987
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideM W Radomski, R M Palmer, S MoncadaEuropean Journal of Pharmacology|October 1, 1977
Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pigG J Dusting, S Moncada, J R VaneBiochemical and Biophysical Research Communications|November 13, 1987
The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumM W Radomski, R M Palmer, S MoncadaProstaglandins|August 1, 1978
Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat pawE A Higgs, S Moncada, J R VaneEuropean Journal of Pharmacology|September 23, 1987
Comparative pharmacology of EDRF and nitric oxide on vascular stripsP J Hutchinson, R M Palmer, S MoncadaThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1980
Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary arteryP M Salzman, J A Salmon, S MoncadaBritish Journal of Pharmacology|October 1, 1990
Characterization of the L-arginine:nitric oxide pathway in human plateletsM W Radomski, R M Palmer, S MoncadaProstaglandins|September 1, 1978
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesB J Whittle, S Moncada, J R VaneProstaglandins|March 1, 1985
Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenaseJ A Salmon, L C Tilling, S MoncadaEuropean Journal of Pharmacology|May 20, 1988
Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cellsD D Rees, R M Palmer, S MoncadaPageof 59